Long-acting antiretrovirals: Are they the future of HIV treatment or will the future pass them by? Researcher Charles W. Flexner recently addressed several common myths.
ABOUT THIS CONFERENCE: The annual Conference on Retroviruses and Opportunistic Infections (CROI) features the latest, most important discoveries in HIV research and science. This year's meeting brings together over 4,000 HIV/AIDS researchers, clinicians and experts, from across the globe. TheBodyPRO.com's coverage of CROI 2017 includes study and presentation summaries, as well as analyses from study authors and leading HIV clinicians/researchers. Please note: TheBodyPRO.com is an independent website not associated with the conference. (Credit: pabradyphoto for iStock via Thinkstock.)
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.